Category: direct-to-consumer

Sesame adds online pharmacy to cash-pay marketplace

cash-pay, Daily, direct-to-consumer, Health Services, New York, Pharmacy, Sesame, SYN, Telehealth, Telemedicine, Top Story / August 31, 2021 August 31, 2021

The startup, where patients access cash-pay telehealth and in-person visits, recently added prescription delivery through Truepill. It’s offering a list of generic medications for $5.

D2C in healthcare: Why now is the perfect time

BioPharma, biopharma nl, Daily, direct-to-consumer, Health Tech, MedCity Influencers, News, SYN, Top Story / July 21, 2021 July 21, 2021

Opportunities exist in many areas of the industry, and patients are hungrier than ever for more engaging and humane experiences. For D2C brands that are ready to capitalize on the changing market, the sky’s the limit.

Sidestepping the system – Is D2C the next winning model in healthcare?

business model, Daily, digital health, direct-to-consumer, Health Tech, MedCity Influencers, SYN, Top Story / May 5, 2021 May 5, 2021

While D2C can enable creativity in customer acquisition and B2B strategies allow for rapid monetization, companies must thoughtfully target consumers, track clinical outcomes, and demonstrate cost-savings.

Strategies that will help make 2021 a banner year for life sciences industries

BioPharma, biopharma nl, Daily, decentralized clinical trials, direct-to-consumer, Health Tech, News, Patient Engagement, SYN, Telemedicine, Top Story / January 26, 2021 January 26, 2021

Covid-19 showed that pharma companies can be nimble and implement changes that prevent processes from weighing down on operations. But which of these operational and strategic changes will stand the test of time and make this year and the future bright for the industry?

After $1.6B blank-check deal, Hims & Hers plots expansion into more conditions

biotech IPO, Daily, direct-to-consumer, HIMS, Hims & Hers, IPO, Retail Health, SYN, Telehealth, Telemedicine, Top Story / January 21, 2021 January 21, 2021

The three-year-old digital health startup began trading on the New York Stock Exchange on Thursday. It merged with a subsidiary of Oaktree Capital Management in a deal that valued the company at $1.6 billion.

Eargo goes public, raising $141.3M

Daily, direct-to-consumer, Eargo, hearing aids, Medical Devices, San Jose, Startups, SYN, Top Story / October 16, 2020 October 16, 2020

The Bay Area hearing device-maker planned to raise $141.3 million in an upsized IPO. Its stock started trading on Nasdaq under the ticker “EAR.”

Hims & Hers to go public through blank-check company

direct-to-consumer, Health Tech, Hims & Hers, Hims Inc, IPO, Oaktree Acquisition Corp, Startups, SYN, Telehealth, Top Story / October 1, 2020 October 1, 2020

The direct-to-consumer telehealth startup will go public through a merger with special purpose acquisition company Oaktree Acquisition Corp. The combined entity is expected to be valued at $1.6 billion.

Telehealth startup brings gender-affirming care to employee benefits programs

Daily, Denver, digital health, direct-to-consumer, Employee Benefits, LGBTQ health, Plume, Startups, SYN, Telehealth, Telemedicine, Top Story / September 29, 2020 September 29, 2020

Plume provides access to telehealth consultations for patients seeking gender-affirming hormone therapy. Recently, the startup began partnering with employers to offer its services as a benefit.

Direct-to-consumer pharmacy company Thirty Madison raises $47M

Daily, direct-to-consumer, Health Services, mail order pharmacy, New York, Pharma, prescription, Startups, SYN, Thirty Madison, Top Story / August 14, 2020 August 14, 2020

Thirty Madison, which owns direct-to-consumer pharmacy brands for hair loss, migraines and acid reflux, raised $47 million in a series B round. Polaris Partners led the round, and Johnson & Johnson participated as an investor.